Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 516

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication

Open access
Bihorac, Azra, Chawla, Lakhmir S., Shaw, Andrew D., Al-Khafaji, Ali, Davison, Danielle L., DeMuth, George E., Fitzgerald, Robert, Gong, Michelle Ng, Graham, Derrel D., Gunnerson, Kyle, Heung, Michael, Jortani, Saeed, Kleerup, Eric, Koyner, Jay L., Krell, Kenneth, LeTourneau, Jennifer, Lissauer, Matthew, Miner, James, Nguyen, H. Bryant, Ortega, Luis M., Self, Wesley H., Sellman, Richard, Shi, Jing, Straseski, Joely, Szalados, James E., Wilber, Scott T., Walker, Michael G., Wilson, Jason, Wunderink, Richard, Zimmerman, Janice, Kellum, John A.·2014·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: We recently reported two novel biomarkers for acute kidney injury (AKI), tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 (IGFBP7), both related to G1 cell cycle arrest. OBJECTIVES: We now validate a clinical test for urinary [TIMP-2]·[IGFBP7] at a high-sensitivity cutoff greater than 0.3 for AKI risk stratification in a diverse population of critically ill patients. METHODS: We conducted a prospective multicenter study of 420 critically ill patients. The primary analysis was the ability of urinary [TIMP-2]·[IGFBP7] to predict moderate to severe AKI within 12 hours. AKI was adjudicated by a committee of three independent expert nephrologists who were masked to the results of the test. MEASUREMENTS AND MAIN RESULTS: Urinary TIMP-2 and IGFBP7 were measured using a clinical immunoassay platform. The primary endpoint was reached in 17% of patients. For a single urinary [TIMP-2]·[IGFBP7] test, sensitivity at the prespecified high-sensitivity cutoff of 0.3 (ng/ml)(2)/1,000 was 92% (95% confidence interval [CI], 85-98%) with a negative likelihood ratio of 0.18 (95% CI, 0.06-0.33). Critically ill patients with urinary [TIMP-2]·[IGFBP7] greater than 0.3 had seven times the risk for AKI (95% CI, 4-22) compared with critically ill patients with a test result below 0.3. In a multivariate model including clinical information, urinary [TIMP-2]·[IGFBP7] remained statistically significant and a strong predictor of AKI (area under the curve, 0.70, 95% CI, 0.63-0.76 for clinical variables alone, vs. area under the curve, 0.86, 95% CI, 0.80-0.90 for clinical variables plus [TIMP-2]·[IGFBP7]). CONCLUSIONS: Urinary [TIMP-2]·[IGFBP7] greater than 0.3 (ng/ml)(2)/1,000 identifies patients at risk for imminent AKI. Clinical trial registered with www.clinicaltrials.gov (NCT 01573962).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201401-0077oc

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 516

Metadata

Authors
Bihorac, A., Chawla, L. S., Shaw, A. D., Al-Khafaji, A., Davison, D. L., DeMuth, G. E., Fitzgerald, R., Gong, M. N., Graham, D. D., Gunnerson, K., Heung, M., Jortani, S., Kleerup, E., Koyner, J. L., Krell, K., LeTourneau, J., Lissauer, M., Miner, J., Nguyen, H. B., Ortega, L. M., Self, W. H., Sellman, R., Shi, J., Straseski, J., Szalados, J. E., Wilber, S. T., Walker, M. G., Wilson, J., Wunderink, R., Zimmerman, J., & Kellum, J. A.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2014-04-15
Volume
189
Issue
8
Pages
932-939
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2169504018
Cited by
516
References
41
FWCI
42.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. https://app.cochat.ai/papers/10.1164/rccm.201401-0077oc
The paper
Bihorac, A., Chawla, L. S., Shaw, A. D., Al-Khafaji, A., Davison, D. L., DeMuth, G. E., Fitzgerald, R., Gong, M. N., Graham, D. D., Gunnerson, K., Heung, M., Jortani, S., Kleerup, E., Koyner, J. L., Krell, K., LeTourneau, J., Lissauer, M., Miner, J., Nguyen, H. B., . . . Kellum, J. A. (2014). Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201401-0077oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.